Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award

Dr. Muhammad Bilal Afridi | Medicine and Health Sciences | Best Researcher Award | Pharmaceutical | Abdul Wali Khan University Mardan | Pakistan

Dr. Muhammad Bilal Afridi is a dedicated pharmaceutical scientist and clinical pharmacist recognized for his expertise in drug synthesis, pharmacological modeling, and computational chemistry. With a profound academic background and more than a decade of professional experience, Dr. Afridi has established himself as a leading researcher in the domain of synthetic and therapeutic drug development. He earned his Ph.D. in Pharmaceutical Sciences from Abdul Wali Khan University, Mardan, where his doctoral research focused on the synthesis, characterization, computational studies, and pharmacological potential of synthetic curcumin derivatives aimed at addressing diabetes and amnesia-related disorders. His earlier academic milestones include an M.Phil in Pharmaceutical Sciences from Abdul Wali Khan University and a Doctor of Pharmacy (Pharm-D) from Kohat University of Science and Technology. Professionally, Dr. Muhammad Bilal Afridi has served as a pharmacist at the Institute of Kidney Diseases (IKD), Peshawar, where he managed hospital pharmacy operations, clinical pharmacy services, and patient safety programs. His leadership extended to training junior pharmacists, supervising pharmacy interns, and participating in institutional Drug and Therapeutic Committees. His previous tenures at Rehman Medical Institute and D. Watson Chemist allowed him to develop robust skills in patient counseling, prescription review, pharmacovigilance, and rational drug use. Dr. Afridi’s research interests encompass computational drug design, molecular docking, pharmacodynamics, and synthesis of bioactive compounds, reflecting his interdisciplinary approach that bridges chemistry, pharmacology, and computational biology. His published works in highly regarded journals, including Computational Biology and Chemistry, Inorganic Chemistry Communications, and Current Molecular Pharmacology, contribute significantly to advancing medicinal chemistry and pharmaceutical innovation. He has demonstrated strong analytical and technical skills in density functional theory (DFT) modeling, ADMET prediction, and spectral analysis. Dr. Muhammad Bilal Afridi’s professional competencies include teaching, mentoring, research supervision, and scientific writing, backed by proficiency in tools like EndNote and MS Office. His contributions have been acknowledged through multiple peer-reviewed publications, collaborations with international researchers from Türkiye and Saudi Arabia, and recognition in academic circles for his commitment to scientific excellence. He continues to serve as a role model for young researchers in Pakistan through his dedication to patient-centered research and academic mentorship. His unwavering commitment to bridging pharmaceutical sciences and clinical applications makes him a strong candidate for recognition in global research excellence. Dr. Muhammad Bilal Afridi stands as an emerging leader with a promising future in international pharmaceutical research, committed to innovation, integrity, and impactful contributions to human health and medicine.

Profile: Scopus

Featured Publications 

  1. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). SwissADME studies and density functional theory (DFT) approaches of methyl substituted curcumin derivatives. Computational Biology and Chemistry, 112, 108153. (Cited by 8)

  2. Afridi, M. B., Sardar, H., Serdaroğlu, G., Shah, S. W. A., Alsharif, K. F., & Khan, H. (2024). In silico ADMET and DFT analysis of methoxy substituted curcumin derivatives. Inorganic Chemistry Communications, 168, 112943. (Cited by 6)

  3. Afridi, M. B., Khan, H., Ali Shah, S. W., Zafar, M., Almalki, A. S., Ghias, M., & Rahman, N. (2022). In-vivo anti-nociceptive activities of Schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies. Main Group Chemistry, 21(2), 373–386. (Cited by 10)

  4. Afridi, M. B., Khan, H., Akkol, E. K., & Aschner, M. (2021). Pain perception and management: Where do we stand? Current Molecular Pharmacology, 14(5), 678–688. (Cited by 25)

  5. Afridi, M. B., Sardar, H., Shah, S. W. A., Serdaroğlu, G., & Khan, H. (2025). Exploring anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives. European Journal of Pharmacology, 950, 182653. (Cited by 2)

  6. Afridi, M. B., Khan, H., & Shah, S. W. A. (2023). Computational evaluation of synthetic curcumin analogs for neuroprotective potential using molecular docking approaches. Journal of Molecular Structure, 1287, 135623. (Cited by 4)

  7. Afridi, M. B., Sardar, H., & Khan, H. (2023). Pharmacological insights into curcumin derivatives: A computational and experimental perspective. Bioorganic Chemistry, 137, 106707. (Cited by 3)

 

Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr . Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Christina Pettan-Brewer | Medicine and Health Sciences | Associate Professor and Director | School of Medicine University of Washington | United States

Associate Professor Dr. Christina Pettan-Brewer is a distinguished veterinary scientist and global health leader whose career bridges research, education, and international policy. With advanced training in veterinary medicine, genetics, epidemiology, and One Health, she has contributed significantly to understanding zoonotic diseases, environmental health, and the genetic and molecular mechanisms of aging and disease. She serves as a key advisor and expert for international organizations including UNEP Nature for Health, WHO, PREZODE, and the International Alliance against Health Risks in Wildlife Trade, demonstrating her influence on global health strategies and pandemic prevention platforms. As Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health, she plays a pivotal role in advancing interdisciplinary scientific communication. Multilingual and internationally engaged, she combines her academic role at the University of Washington with mentorship, Fulbright program leadership, and advocacy for underrepresented groups in science, making her a recognized authority in One Health, planetary health, and global public health innovation.

Professional Profile 

Education  

Associate Professor Dr. Christina Pettan-Brewer has a strong and diverse educational background that reflects her interdisciplinary expertise. She began her academic journey in Brazil, earning a technical degree in Zoology and Clinical Pathology, followed by a Doctor of Veterinary Medicine with honors from the Universidade Federal de Viçosa. She then pursued advanced studies in the United States at the University of California, Davis, completing a Master of Science in Wildlife and Zoological Medicine and Comparative Pathology while also receiving accreditation as a Doctor of Veterinary Medicine. To further strengthen her expertise in global health, she obtained a PhD in One Health and Global Health from the Federal University of Paraná in collaboration with the University of Colorado, specializing in Indigenous Health and Emerging Infectious Diseases. Her educational achievements, marked by honors and top performance, form the foundation of her career in veterinary medicine, public health, genetics, and planetary health.

Professional Experience

Associate Professor Dr. Christina Pettan-Brewer has built an impressive professional career that integrates academic leadership, research, and international advisory roles. She began her faculty journey as an Assistant Professor at Centenary University in New Jersey, where she developed curricula for pre-veterinary and pre-medicine programs while conducting research on avian pathology during the West Nile Virus outbreak. At the University of Washington School of Medicine, she has advanced through roles as Acting Instructor, Acting Assistant Professor, and now Associate Professor in the Department of Comparative Medicine, contributing extensively to research in genetics, zoonotic diseases, and One Health. Beyond academia, she has served as a senior advisor and technical expert for global organizations such as UNEP, WHO, PREZODE, and international veterinary associations, shaping global health strategies and pandemic preparedness. Her editorial leadership with CABI One Health and Beyond One Ocean Health further demonstrates her influence in scientific communication, while her Fulbright program advisory role highlights her dedication to mentoring and international academic exchange.

Research Interest

Associate Professor Dr. Christina Pettan-Brewer’s research interests lie at the intersection of veterinary medicine, public health, and planetary health, with a strong emphasis on the One Health approach. She focuses on zoonotic and emerging infectious diseases, pandemic prevention, and the interconnectedness of human, animal, and environmental health. Her work extends to the genetic and molecular mechanisms of aging, chronic diseases, and susceptibility to toxins, as well as the health impacts of climate change and biodiversity loss. She is particularly interested in Indigenous health, global health equity, and the role of wildlife and ecosystem preservation in preventing future pandemics. Through her interdisciplinary research, she seeks to advance collaborative solutions that strengthen global health systems, protect vulnerable populations, and promote sustainable, resilient communities

Award and Honor

Associate Professor Dr. Christina Pettan-Brewer has been recognized with numerous honors and prestigious appointments that highlight her global leadership in One Health and public health. She has served as a United Nations Environment Programme (UNEP) One Health Expert and Technical Advisory Group member for the Nature for Health initiative, representing Latin America and later co-chairing its expert committee. Her expertise has been sought by the World Health Organization’s Global Preparedness Monitoring Board, PREZODE’s International Data Working Group, and the Agence Nationale de la Recherche in France for evaluating pandemic prevention strategies. She has also been appointed as a Fulbright Program Adviser, National Scholar Program Ambassador, and Reviewer, reflecting her commitment to international education and research exchange. In addition, her editorial leadership roles as Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health stand as significant honors that demonstrate her influence in shaping global scientific dialogue. These achievements collectively underscore her distinguished reputation as a trusted advisor, scholar, and thought leader in global health.

Publications Top Noted

Effects of Covid-19 Pandemic in the Surveillance and Control of Neglected Tropical Diseases and Malaria: A Systematic Review

Year: 2025

Protecting Urban Wildlife Fauna, Fighting Zoonoses, and Preventing Biophobia in Brazil

Year: 2025

Conclusion

Dr. Christina Pettan-Brewer is a highly suitable candidate for the Best Researcher Award. Her career exemplifies global leadership, interdisciplinary research, and a strong commitment to advancing One Health, pandemic prevention, and planetary health. With a proven record of academic excellence, international collaboration, and impactful advisory roles, she stands out as a researcher whose work bridges science, policy, and education. Addressing minor improvements related to visibility of individual research outputs would further strengthen her profile, but her broad and meaningful contributions make her a compelling and deserving nominee for this recognition.